For More Information
Contact Us
OvaStem® is a patented stem cell based treatment for treatment of premature ovarian insufficiency/failure. It is provided by Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company committed to improving patient lives in the areas of urology, orthopedics, and gynecology utilizing stem cells derived from autologous bone marrow. OvaStem® is the direct result of research and collaboration between some of the preeminent scientists and physicians in the world who specialize in gynecology, obstetrics, reproductive endocrinology, and stem cell therapy.
OvaStem® is a cutting edge technology currently being developed by leaders in the field of regenerative medicine, reproductive endocrinology, and gynecology as a treatment option for premature ovarian insufficiency of failure. The procedure offers the possibility of pregnancy without the requirement of a donor egg.
Polonio, A. M., García-Velasco, J. A., & Herraiz, S. (2020). Stem Cell Paracrine Signaling for Treatment of Premature Ovarian Insufficiency.
Front Endocrinol (Lausanne), 11, 626322. https://doi.org/10.3389/fendo.2020.626322
Contact Us
